Arthritis Care & Research
Author Guidelines
Manuscripts should be submitted online at:
http://mc.manuscriptcentral.com/acr
Arthritis Care & Research Editor: Marian T. Hannan, DSc, MPH
Hebrew SeniorLife and Harvard Medical School, Boston, MA.
Editorial office phone: 919-650-1459
E-mail: ACReditor@jjeditorial.com
Articles are accepted for publication on the condition that they are submitted to this journal only. Articles should pertain to the field of rheumatic disease.
Manuscripts not in compliance with the following instructions may be subject to a delay in the review process.
Arthritis Care & Research, an official journal of the American College of Rheumatology and the Association of Rheumatology Professionals (a division of the College), is a peer-reviewed publication that publishes original research, review articles, and editorials that promote excellence in the clinical practice of rheumatology. Relevant to the care of individuals with rheumatic diseases, major topics are evidence-based practice studies, clinical problems, practice guidelines, educational, social, and public health issues, health economics, health care policy, and future trends in rheumatology practice.
Author Guidelines Table of Contents
Format and organization
Original Articles
Clinicopathologic Conferences (CPC)
Brief Reports
Review Articles
Letters to the Editor
Video Abstracts
English-language editing service
Content, acronyms, and terminology
Statistical Reporting
Clinical assessment instruments
Compliance with research ethics standards
Illustrations
Tables
Supplementary material
References
Assignment of reviewers
Related manuscripts/duplicate publication
Authorship criteria
Disclosure of interest
Copyright: Wiley Author Licensing Service
Author corrections on proofs
Page charges
Format and organization
Manuscripts not in compliance with the following instructions may be subject to a delay in the review process.
Submit all new manuscripts online. Launch your web browser and go to http://mc.manuscriptcentral.com/acr. Check for an existing account. If you are submitting for the first time, create a new account. Follow all instructions. At the end of a successful submission, a confirmation screen with manuscript number will appear and you will receive an e-mail confirming that the manuscript has been received by the journal. If this does not happen, please check your submission and/or contact tech support at ts.mcsupport@thomson.com.
Submit manuscript and all figures as one file if possible. You do not need to mail any copies.
An electronic cover letter should accompany the manuscript. Note in cover letter what type of manuscript is enclosed (Original Article, CPCs, Brief Report, Review Article, or Letter to the Editor). Confirm that each individual named as an author meets the journal's criteria for authorship (listed in the Authorship Criteria section below).
Confirm in the cover letter that the manuscript has not been submitted or is not simultaneously being submitted elsewhere, is not at the time of submission under consideration by another journal or other publication, and that no portion of the data has been or will be published elsewhere while the manuscript is under review by the journal, unless rejected by Arthritis Care & Research or withdrawn by the author(s). If a manuscript is in “revision suggested” status with another journal, it is interpreted to be still under consideration by that journal; for the manuscript to be submitted to Arthritis Care & Research, it must first be officially withdrawn from consideration with the other journal. Similarly, a manuscript that is in “revision suggested” status with Arthritis Care & Research is deemed to be under consideration and may not be submitted to another journal unless the submission is withdrawn from Arthritis Care & Research.
Also confirm that no portion of the data has been or will be published elsewhere while the manuscript is under review by Arthritis Care & Research. Publication in proceedings or transactions of meetings or symposium volumes is considered to be prior publication that renders the manuscript ineligible. Currently publication on a preprint server also is considered by the journal to be prior publication. However, in the case of studies not involving clinical data, the authors are encouraged to contact the journal when advance submission to a preprint server is being considered, as exceptions may be granted. The publication of data in abstracts, and presentation in oral or poster sessions at meetings, do not constitute previous publication unless the abstract exceeds two pages in length and/or is cited in PubMed.
Indicate any financial support or other benefits from commercial sources for the work reported on in the manuscript, or any other financial interests that any of the authors may have, which could create a potential conflict of interest or the appearance of a conflict of interest with regard to the work. Corresponding author should include address, telephone number, fax number, and E-mail address.
Type all pages of the manuscript, including those containing references, tables, and figure legends, double space in 12-point type, with 1- to 1½-inch margins. Number all sheets in succession, including references, tables, and figure legends. Title page is page 1. On the first page, type the running head (short title for top of each page), title (which cannot include any acronyms), name(s) of the author(s) and their major degrees, grant(s) or other financial supporter(s) of the study, address for correspondence and corresponding author's telephone and fax numbers and E-mail address. Also indicate the word count for the manuscript (not including abstract, references, tables, and figure legends). The word and table/figure limits are outlined for each manuscript type below.
Also on the first page, again indicate any financial support or other benefits from commercial sources for the work reported on in the manuscript, or any other financial interests that any of the authors may have, which could create a potential conflict of interest or the appearance of a conflict of interest with regard to the work.
ORCID
Arthritis Care & Research requires the submitting author (only) to provide an ORCID iD when submitting a manuscript.
Original Articles
Original Articles are descriptions of original research that adds to the body of knowledge in arthritis and the rheumatic diseases.
On the second page of Original Articles include an abstract of fewer than 250 words. The abstract should be divided into the following sections: Objective, Methods, Results, and Conclusion.
On the third page, included a section titled Significance and Innovations. Provide 2-4 bullet points highlighting the significant and/or innovative findings from your article.
On the fourth page, begin the introduction(no heading is necessary). Follow this plan of organization: Materials and Methods (or Patients and Methods), Results, Discussion, References, Tables, and Figure Legends.
Original Articles should not exceed 3,800 words from introduction through discussion (not including references, tables, and figure legends). The total number of tables and figures combined may not exceed 6, and the number of references may not exceed 50.
Clinicopathologic Conferences (CPC)
CPCs emphasize new ideas in medical science that shed light on the approach to diagnosis, disease management, or an emerging aspect of pathophysiology. The editors welcome queries about cases that might be appropriate subjects for CPCs, and invite submissions of CPCs.
No abstract is necessary. On the second page, begin the case presentation using the following headings (as applicable): Case Presentation (history of the present illness, past medical history, social and family history, review of systems, physical examination, laboratory evaluation) Case Summary, Differential Diagnosis, Discussion, the Patients' Course, Final Diagnosis.
Brief Reports
Brief reports are short articles of original research consistent with the mission of Arthritis Care & Research to publish articles relevant to clinical care and public policy for people with rheumatic diseases.
Brief reports should not exceed 2,500 words from introduction through discussion. On the second page, include an abstract of fewer than 250 words. The abstract should be divided into the following sections: Objective, Methods, Results, and Conclusion. On the third page, include a section titled Significance and Innovations. Provide 2-4 bullet points highlighting the significant and/or Innovative findings from your article. The total number of tables and figures combined may not exceed 3, and the number of references may not exceed 15.
Review Articles
Review Articles are discussions of clinical, economic, or basic science issues involved in arthritis care and research.
Review Articles should not exceed 3,800 words from introduction through references. The total number of tables and figures combined may not exceed 3. This category does not apply to Systematic Reviews. Please submit Systematic Reviews as Original Articles and follow the format for Original Articles.
Letters to the Editor
Letters to the Editor should be limited to commentaries on previous articles published in Arthritis Care & Research and issues affecting rheumatology and the American College of Rheumatology. Letters that are commentaries on previous articles must be submitted within 6 months after publication of the article. The authors of the article being commented on will be invited to submit a reply letter. Subsequent letters commenting on this reply letter will not be accepted. Length of Letters to the Editor should be no more than 2 pages, including references. Only 1 table or figure may accompany a Letter to the Editor.
Video Abstracts
Arthritis & Rheumatology (A&R), Arthritis Care & Research (AC&R), and ACR Open Rheumatology (ACROR), now offer authors of accepted articles the opportunity to present their research visually through the use of video abstracts. A video abstract succinctly describes the purpose, methods, results, and relevance of a given study within approximately 3–5 minutes. These videos are intended for a medical/clinical audience of physicians and other health professionals, including those in general fields and specialties outside the practice and research of rheumatology.
Submission information
Video abstracts must be submitted during the manuscript revision process as a supplemental file.
Please do not try to upload a video abstract upon initial submission of your manuscript.
Videos should be submitted through the A&R/AC&R/ACRORScholarOne submission website as follows:
When submitting your revised manuscript, please indicate "yes" to the question, "Would you be interested in submitting a video abstract with your revised manuscript?"
Upload the video using the Video Abstract file designation.
Please note: video files too large to upload in ScholarOne may be alternately submitted as a URL for downloading (via a file transfer or cloud storage website, such as Dropbox). In these cases, include the URL link to the video file in a Word file using the Video Abstract file designation.
Video abstract formats
Authors may create a live-action video of the author(s) discussing the research or a narrated video with clips of data or schematic/clinical slides interspersed throughout the discussion.
Authors may create an animated video using graphics and voiceovers to illustrate concisely the concepts and mechanisms in the study.
If appropriate and pertinent, the author may (with permissions) include live-action video of patients demonstrating clinical conditions, and/or health care professionals demonstrating clinical/laboratory techniques.
Authors may use a videography company at the authors’ expense to produce their video abstract. One such company used by Wiley is Research Square; however, authors may use a company of their choice. Professionally produced videos use animation, graphics, and voiceovers to present and highlight the findings of the article.
Before you start, please be aware of the following:
Video abstracts are created, whether by the author(s) or by a videography company, at the author’s expense. For studies with commercial support, the supporting company might assist with video production/expense. Academic institutions might have staff and production resources that are available to the author(s).
Video abstracts will not be copyedited by the journal staff and therefore should be carefully reviewed and edited by the author(s) before final submission. Video abstracts will, however, be reviewed by the journal editors prior to publication.
Authors will need to attest to the following: 1) that the findings described in the video do not extend beyond the findings presented in the accepted article, and 2) that all coauthors of the accepted article agree with the final content of the video abstract.
For institutional postings of the video abstract, authors should post only the journal-approved version of the video.
It is the author’s responsibility to obtain and include the appropriate permissions for previously published material, as well as permissions for videos involving human subjects.
Due to copyright policy, videos must not include music soundtracks (this also applies to open-source music).
Content guidelines
Authors must provide a script of the video at time of submission.
Video abstracts must include authors’ financial disclosures and sources of funding for the study as reported in the title page footnotes of the accepted article.
Video abstracts must include a full citation of the accepted article (authors, title, and publication information).
Video abstracts must include the A&R, AC&R, or ACROR logo, i.e., specific to the journal in which the article was published.
Permissions are required for previously published materials and involvement of human subjects.
Company logos/marketing graphics and brand names are not permitted on the videos.
Institutional copyright insignias are not permitted on the videos.
Video abstracts should illustrate the key findings in a concise and informative manner, and the findings described in the video should not extend beyond the findings presented in the accepted article.
Editors reserve the right to request additional video editing by the authors (which may delay publication).
Provided that the content does not include study findings beyond those reported in the article, authors are encouraged to include additional relevant and illustrative material, such as laboratory footage, histologic images, clinical examination features, and figures/schematics.
Video abstract content should be understandable to medical/clinical professionals who are not necessarily basic science researchers and whose patients might benefit from the findings of the study.
If the narrator is not a medical professional (i.e., possibly unfamiliar with the pronunciation of medical/pharmaceutical terms), authors must ensure that all terms are pronounced correctly in the video before submission.
Technical specifications
It is important that the overall quality of videos be as high as possible and this must be assured at the submission stage. All submitted videos will be reviewed initially for audio/visual clarity and quality.
Video length should be 3–5 minutes.
In schematics and figures, please keep in mind readability and font size. Presentations should not include small text or images that will be difficult to see.
Please create videos with commonly used codecs. Recommended file formats for video files are Quicktime, MPEG, and Avi. (These are the standard codecs/file formats of videos created on smartphones and tablets.)
Restrict individual file sizes to 10MB or less (zipped or unzipped) as larger files can lead to download issues for users.
Please test video files before submission, preferably on computers not used for the video file’s creation, in order to check for compatibility issues.
English-language editing service
Click here to send your manuscript to Wiley English Language Editing Service. The English Language Editing Service can help to ensure your paper is clearly written in standard, scientific English language appropriate to your discipline. Visit our site to learn about the options. Using the Wiley English Language Editing Service does not guarantee that your paper will be accepted for publication.
NOTE: Using this link will NOT submit your manuscript to the journal - it opens a new window for the English Language Editing Service.
Content, acronyms, and terminology
Do not use new technical words, laboratory slang, words not defined in dictionaries, or abbreviations or terminology not consistent with internationally accepted guidelines. Define any abbreviations the first time they are used. A list of acronyms for many common rheumatology terms has been developed by an international group of rheumatology journal editors. Names of and acronyms for genes and proteins should comply with their official entries in Entrez Gene and UniProt, respectively.
In order to make the description of patients as clear as possible and to facilitate comparisons with other studies, the Methods section should include, whenever possible, a short paragraph detailing the proportion of patients who satisfy the ACR classification criteria for the particular disease described.
Statistical reporting
The journal’s statistical consultants recommend that statistical best practices be followed in the design and reporting of research studies. In addition, it is strongly recommended that authors include the appropriate reporting checklist based on the given study type (see reporting guidelines). This is for use in the review process only, and therefore should be included as a separate document from the manuscript.
For all studies, the Methods section of the manuscript should contain descriptions of 1) sample size and power considerations for the study; 2) the methods for primary and secondary analyses; and 3) how missing data have been handled (complete case analyses that include only subjects with complete data are rarely appropriate). The Results section should include 1) confidence intervals for estimate effect sizes, measures of association, or other parameters of interest and 2) 2-sided P values in almost all circumstances where hypotheses are being tested, such as a randomize controlled trial. Results should be presented with no more precision than is of scientific value and is meaningful given the available sample size.
Further details on statistical reporting for specific study types (clinical trials, observational studies, and preclinical and translational studies) are provided in the journal’s Guide to Statistical Reporting for Specific Study Types in ACR Journals.
……
更多详情：
https://onlinelibrary.wiley.com/page/journal/21514658/homepage/forauthors.html
